Promising Future Outlook for Whole Genome Sequencing Market
RNCOS research report on “US Personalized Cancer Genome Sequencing Market” says that the personalized cancer whole genome sequencing market has a promising future and represents the potential to reach around US$ 9 Billion by 2017. Despite of the high costs for Whole Genome Sequencing, the market boasts of a huge potential of customer base favoring personalized treatment for cancer. The whole genome sequencing approach would take down the cost of treatment from millions to dollars to much less than diagnostic...
View full press release